Table 3.
Patient preference |
Complexity of mechanisms that lead to the clinical expression of motor and nonmotor subtypes of PD |
The need for multimodal and not single biomarkers |
The need to take into account various strands of personalised medicine |
The fact that advanced PD implies duration of disease while complex refers to the conditional stage and incorporates the concept that early PD can also be complex |